Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
The outcome of overall survival, PSA doubling time, and final PSA level in response and non-response groups of second-line hormonal therapy.
| All | Response | Non-response | P value | |
|---|---|---|---|---|
| (n = 223) | (n = 65) | (n = 158) | ||
| Overall survival (month) | 10.5 (6.4–17.4) | 12.3 (9.9–19.9) | 9.6 (5.3–15.9) | <0.01* |
| PSA doubling time (month) | 5.0 (2.5–9.8) | 9.0 (4.4–11.6) | 3.9 (2.2–9.1) | <0.01* |
| Final PSA level (ng/mL) | 186.8 (30.5–968.1) | 23.3 (0.9–187.4) | 277.8 (50.1–1281.2) | 0.03* |
*p < 0.05.
PSA, prostatic specific antigen.
